Global Amlodipine and Olmesartan Market Research Report 2021-2027

  • receipt Report ID : 221897
  • calendar_today Published On: Jul, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare

The Amlodipine and Olmesartan market report offers in in-dept analysis on the global market size, market share, market growth, sales analysis, regional analysis, market developments, opportunities, and forecasts that will help you in strategizing and expanding your business.

As per the most recent analysis conducted by our research team, the global Amlodipine and Olmesartan market size is projected to reach US$ XX million by 2027 from US $ XX million in 2020 at a CAGR of XX% during 2021-2027.

The report included detailed analysis on the Amlodipine and Olmesartan production capacity, its market share by manufacturers, growth rate, regional production capacity, ex-factory rate, and other important data points. The report also covers Amlodipine and Olmesartan consumption globally as well as thorough bifurcation into regional and country wise consumption.

The research team goes an additional mile to comprehensively cover other important aspects on Amlodipine and Olmesartan market such as the market dynamics, market segmentation, competition, growth prospects, and growth strategies. The buyers of this report will have access to exclusive data that covers market share by applications, manufacturers, regions, and countries. The document also covers market size by type, market competition by manufacturers, sales volume, growth rate, revenue, price and gross margins. Moreover, the authors of this report provide authentic calculations and estimations for global revenue and volume by type segments for Amlodipine and Olmesartan market covering the period 2016-2027.

This report includes the following key manufacturers. We can also add other companies of your choice and customize the report as per your requirements.

  • Daiichi Sankyo
  • Teva
  • Glenmark Pharmaceuticals
  • Matrix Laboratories
  • Torrent Pharmaceuticals
  • Aurobindo
  • Macleods Pharmaceuticals
  • Alembic Pharmaceuticals
  • Ajanta Pharma
  • Jubilant Pharma
  • Accord Healthcare

Market Segment by Type

  • 5/20 mg Tablets
  • 10/20 mg Tablets
  • 5/40 mg Tablets
  • 10/40 mg Tablets

Market Segment by Application

  • Hospital
  • Drug store

Market Segment by Regions and Countries

  • North America (United States, Canada, Mexico)
  • Asia-Pacific (China, India, Japan, Taiwan, South Korea, Australia, Indonesia, Singapore, Malaysia, Rest of Asia-Pacific)
  • Europe (Germany, France, UK, Italy, Spain, Russia, Rest of Europe)
  • Central & South America (Brazil, Argentina, Rest of South America)
  • Middle East & Africa (Saudi Arabia, UAE, Turkey, Rest of Middle East & Africa)

The study objectives of this report are:

  • Overview of the Amlodipine and Olmesartan market
  • Analysis on key market segments
  • Key manufacturer analysis based on production, sales, and revenue
  • Amlodipine and Olmesartan market regional and country wise analysis for production and consumption
  • Study the forecast of market in respect to manufacturers, segments, and regions
  • Identify significant trends and factors driving the market growth
  • Analyse the available opportunities in the market by tracing high growth segments
  • Analyse competitive developments like acquisitions, expansions, product launches, agreements, etc.
  • Study the growth strategies of key manufacturers
  • SWOT analysis

In this study, the years considered to estimate the market size of Amlodipine and Olmesartan are as follows:

History Year: 2016-2020

Base Year: 2020

Estimated Year: 2021

Forecast Year 2021 to 2027

Available Customizations

Market Research Place offers customizations according to the client's specific needs. The report can be customized on the basis of manufacturers, regions, applications, etc. Contact us to know more about the customization options.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Report Overview

1.1 Research Scope

1.2 Market Segment by Type

1.2.1 Global Amlodipine and Olmesartan Market Size Growth Rate by Type

1.2.2 5/20 mg Tablets

1.2.3 10/20 mg Tablets

1.2.4 5/40 mg Tablets

1.2.5 10/40 mg Tablets

1.3 Market Segment by Application

1.3.1 Global Amlodipine and Olmesartan Market Share by Application (2016 VS 2021 VS 2027)

1.3.2 Hospital

1.3.3 Drug store

1.4 Study Objectives

1.5 Years Considered

2 Market Perspective

2.1 Global Amlodipine and Olmesartan Market Size (2016-2027)

2.1.1 Global Amlodipine and Olmesartan Revenue (2016-2027)

2.1.2 Global Amlodipine and Olmesartan Sales (2016-2027)

2.2 Global Amlodipine and Olmesartan Market Size across Key Geographies Worldwide: 2016 VS 2021 VS 2027

2.2.1 Global Amlodipine and Olmesartan Sales by Regions (2016-2021)

2.2.2 Global Amlodipine and Olmesartan Revenue by Regions (2016-2021)

2.3 Global Amlodipine and Olmesartan Market Size Forecast by Region

2.3.1 Global Amlodipine and Olmesartan Sales Forecast by Region (2022-2027)

2.3.2 Global Amlodipine and Olmesartan Revenue Forecast by Region (2022-2027)

2.4 Global Top Amlodipine and Olmesartan Regions (Countries) Ranking by Market Size

2.5 Amlodipine and Olmesartan Industry Trends

2.5.1 Amlodipine and Olmesartan Market Trends

2.5.2 Amlodipine and Olmesartan Market Drivers

2.5.3 Amlodipine and Olmesartan Market Challenges

2.5.4 Amlodipine and Olmesartan Market Restraints

3 Competitive Landscape by Manufacturers

3.1 Global Top Amlodipine and Olmesartan Manufacturers by Sales (2016-2021)

3.1.1 Global Amlodipine and Olmesartan Sales by Manufacturers (2016-2021)

3.1.2 Global Amlodipine and Olmesartan Sales Market Share by Manufacturers (2016-2021)

3.1.3 Global 5 and 10 Largest Manufacturers by Amlodipine and Olmesartan Sales in 2020

3.2 Global Top Manufacturers Amlodipine and Olmesartan by Revenue

3.2.1 Global Amlodipine and Olmesartan Revenue by Manufacturers (2016-2021)

3.2.2 Top Amlodipine and Olmesartan Manufacturers Covered: Ranking by Revenue

3.2.3 Global Amlodipine and Olmesartan Revenue Share by Manufacturers (2016-2021)

3.2.4 Global Amlodipine and Olmesartan Market Concentration Ratio (CR5 and HHI)

3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Amlodipine and Olmesartan as of 2020)

3.4 Global Amlodipine and Olmesartan Average Selling Price (ASP) by Manufacturers

3.5 Key Manufacturers Amlodipine and Olmesartan Plants/Factories Distribution and Area Served

3.6 Date of Key Manufacturers Enter into Amlodipine and Olmesartan Market

3.7 Key Manufacturers Amlodipine and Olmesartan Product Offered

3.8 Mergers & Acquisitions, Expansion Plans

4 Global Amlodipine and Olmesartan Market Size by Type

4.1 Global Amlodipine and Olmesartan Historic Market Review by Type (2016-2021)

4.1.1 Global Amlodipine and Olmesartan Sales Market Share by Type (2016-2021)

4.1.2 Global Amlodipine and Olmesartan Revenue Market Share by Type (2016-2021)

4.1.3 Amlodipine and Olmesartan Price by Type (2016-2021)

4.2 Global Amlodipine and Olmesartan Market Estimates and Forecasts by Type (2022-2027)

4.2.1 Global Amlodipine and Olmesartan Sales Forecast by Type (2022-2027)

4.2.2 Global Amlodipine and Olmesartan Revenue Forecast by Type (2022-2027)

4.2.3 Amlodipine and Olmesartan Price Forecast by Type (2022-2027)

5 Global Amlodipine and Olmesartan Market Size by Application

5.1 Global Amlodipine and Olmesartan Historic Market Review by Application (2016-2021)

5.1.1 Global Amlodipine and Olmesartan Sales Market Share by Application (2016-2021)

5.1.2 Global Amlodipine and Olmesartan Revenue Market Share by Application (2016-2021)

5.1.3 Amlodipine and Olmesartan Price by Application (2016-2021)

5.2 Global Amlodipine and Olmesartan Market Estimates and Forecasts by Application (2022-2027)

5.2.1 Global Amlodipine and Olmesartan Sales Forecast by Application (2022-2027)

5.2.2 Global Amlodipine and Olmesartan Revenue Forecast by Application (2022-2027)

5.2.3 Amlodipine and Olmesartan Price Forecast by Application (2022-2027)

6 North America

6.1 North America Amlodipine and Olmesartan Sales Breakdown by Company

6.1.1 North America Amlodipine and Olmesartan Sales by Company (2016-2027)

6.1.2 North America Amlodipine and Olmesartan Revenue by Company (2016-2027)

6.2 North America Amlodipine and Olmesartan Market Size by Type (2016-2027)

6.2.1 North America Amlodipine and Olmesartan Sales by Type (2016-2027)

6.2.2 North America Amlodipine and Olmesartan Revenue by Type (2016-2027)

6.3 North America Amlodipine and Olmesartan Market Size by Application (2016-2027)

6.3.1 North America Amlodipine and Olmesartan Sales by Application (2016-2027)

6.3.2 North America Amlodipine and Olmesartan Revenue by Application (2016-2027)

6.4 North America Amlodipine and Olmesartan Market Size by Country

6.4.1 North America Amlodipine and Olmesartan Sales by Country (2016-2027)

6.4.2 North America Amlodipine and Olmesartan Revenue by Country (2016-2027)

6.4.3 U.S.

6.4.4 Canada

7 Europe

7.1 Europe Amlodipine and Olmesartan Sales Breakdown by Company

7.1.1 Europe Amlodipine and Olmesartan Sales by Company (2016-2027)

7.1.2 Europe Amlodipine and Olmesartan Revenue by Company (2016-2027)

7.2 Europe Amlodipine and Olmesartan Market Size by Type (2016-2027)

7.2.1 Europe Amlodipine and Olmesartan Sales by Type (2016-2027)

7.2.2 Europe Amlodipine and Olmesartan Revenue by Type (2016-2027)

7.3 Europe Amlodipine and Olmesartan Market Size by Application (2016-2027)

7.3.1 Europe Amlodipine and Olmesartan Sales by Application (2016-2027)

7.3.2 Europe Amlodipine and Olmesartan Revenue by Application (2016-2027)

7.4 Europe Amlodipine and Olmesartan Market Size by Country

7.4.1 Europe Amlodipine and Olmesartan Sales by Country (2016-2027)

7.4.2 Europe Amlodipine and Olmesartan Revenue by Country (2016-2027)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

8 Asia Pacific

8.1 Asia Pacific Amlodipine and Olmesartan Sales Breakdown by Company

8.1.1 Asia Pacific Amlodipine and Olmesartan Sales by Company (2016-2027)

8.1.2 Asia Pacific Amlodipine and Olmesartan Revenue by Company (2016-2027)

8.2 Asia Pacific Amlodipine and Olmesartan Market Size by Type (2016-2027)

8.2.1 Asia Pacific Amlodipine and Olmesartan Sales by Type (2016-2027)

8.2.2 Asia Pacific Amlodipine and Olmesartan Revenue by Type (2016-2027)

8.3 Asia Pacific Amlodipine and Olmesartan Market Size by Application (2016-2027)

8.3.1 Asia Pacific Amlodipine and Olmesartan Sales by Application (2016-2027)

8.3.2 Asia Pacific Amlodipine and Olmesartan Revenue by Application (2016-2027)

8.4 Asia Pacific Amlodipine and Olmesartan Market Size by Regions

8.4.1 Asia Pacific Amlodipine and Olmesartan Sales by Regions

8.4.2 Asia Pacific Amlodipine and Olmesartan Revenue by Regions

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 India

8.4.7 Australia

8.4.8 Taiwan

8.4.9 Indonesia

8.4.10 Thailand

8.4.11 Malaysia

8.4.12 Philippines

8.4.13 Vietnam

9 Latin America

9.1 Latin America Amlodipine and Olmesartan Sales Breakdown by Company

9.1.1 Latin America Amlodipine and Olmesartan Sales by Company (2016-2027)

9.1.2 Latin America Amlodipine and Olmesartan Revenue by Company (2016-2027)

9.2 Latin America Amlodipine and Olmesartan Market Size by Type (2016-2027)

9.2.1 Latin America Amlodipine and Olmesartan Sales by Type (2016-2027)

9.2.2 Latin America Amlodipine and Olmesartan Revenue by Type (2016-2027)

9.3 Latin America Amlodipine and Olmesartan Market Size by Application (2016-2027)

9.3.1 Latin America Amlodipine and Olmesartan Sales by Application (2016-2027)

9.3.2 Latin America Amlodipine and Olmesartan Revenue by Application (2016-2027)

9.4 Latin America Amlodipine and Olmesartan Market Size by Country

9.4.1 Latin America Amlodipine and Olmesartan Sales by Country (2016-2027)

9.4.2 Latin America Amlodipine and Olmesartan Revenue by Country (2016-2027)

9.4.3 Mexico

9.4.4 Brazil

9.4.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Amlodipine and Olmesartan Sales Breakdown by Company

10.1.1 Middle East and Africa Amlodipine and Olmesartan Sales by Company (2016-2027)

10.1.2 Middle East and Africa Amlodipine and Olmesartan Revenue by Company (2016-2027)

10.2 Middle East and Africa Amlodipine and Olmesartan Market Size by Type (2016-2027)

10.2.1 Middle East and Africa Amlodipine and Olmesartan Sales by Type (2016-2027)

10.2.2 Middle East and Africa Amlodipine and Olmesartan Revenue by Type (2016-2027)

10.3 Middle East and Africa Amlodipine and Olmesartan Market Size by Application (2016-2027)

10.3.1 Middle East and Africa Amlodipine and Olmesartan Sales by Application (2016-2027)

10.3.2 Middle East and Africa Amlodipine and Olmesartan Revenue by Application (2016-2027)

10.4 Middle East and Africa Amlodipine and Olmesartan Market Size by Country

10.4.1 Middle East and Africa Amlodipine and Olmesartan Sales by Country (2016-2027)

10.4.2 Middle East and Africa Amlodipine and Olmesartan Revenue by Country (2016-2027)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 U.A.E

11 Company Profiles

11.1 Daiichi Sankyo

11.1.1 Daiichi Sankyo Corporation Information

11.1.2 Daiichi Sankyo Overview

11.1.3 Daiichi Sankyo Amlodipine and Olmesartan Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.1.4 Daiichi Sankyo Amlodipine and Olmesartan Products and Services

11.1.5 Daiichi Sankyo Amlodipine and Olmesartan SWOT Analysis

11.1.6 Daiichi Sankyo Recent Developments

11.2 Teva

11.2.1 Teva Corporation Information

11.2.2 Teva Overview

11.2.3 Teva Amlodipine and Olmesartan Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.2.4 Teva Amlodipine and Olmesartan Products and Services

11.2.5 Teva Amlodipine and Olmesartan SWOT Analysis

11.2.6 Teva Recent Developments

11.3 Glenmark Pharmaceuticals

11.3.1 Glenmark Pharmaceuticals Corporation Information

11.3.2 Glenmark Pharmaceuticals Overview

11.3.3 Glenmark Pharmaceuticals Amlodipine and Olmesartan Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.3.4 Glenmark Pharmaceuticals Amlodipine and Olmesartan Products and Services

11.3.5 Glenmark Pharmaceuticals Amlodipine and Olmesartan SWOT Analysis

11.3.6 Glenmark Pharmaceuticals Recent Developments

11.4 Matrix Laboratories

11.4.1 Matrix Laboratories Corporation Information

11.4.2 Matrix Laboratories Overview

11.4.3 Matrix Laboratories Amlodipine and Olmesartan Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.4.4 Matrix Laboratories Amlodipine and Olmesartan Products and Services

11.4.5 Matrix Laboratories Amlodipine and Olmesartan SWOT Analysis

11.4.6 Matrix Laboratories Recent Developments

11.5 Torrent Pharmaceuticals

11.5.1 Torrent Pharmaceuticals Corporation Information

11.5.2 Torrent Pharmaceuticals Overview

11.5.3 Torrent Pharmaceuticals Amlodipine and Olmesartan Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.5.4 Torrent Pharmaceuticals Amlodipine and Olmesartan Products and Services

11.5.5 Torrent Pharmaceuticals Amlodipine and Olmesartan SWOT Analysis

11.5.6 Torrent Pharmaceuticals Recent Developments

11.6 Aurobindo

11.6.1 Aurobindo Corporation Information

11.6.2 Aurobindo Overview

11.6.3 Aurobindo Amlodipine and Olmesartan Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.6.4 Aurobindo Amlodipine and Olmesartan Products and Services

11.6.5 Aurobindo Amlodipine and Olmesartan SWOT Analysis

11.6.6 Aurobindo Recent Developments

11.7 Macleods Pharmaceuticals

11.7.1 Macleods Pharmaceuticals Corporation Information

11.7.2 Macleods Pharmaceuticals Overview

11.7.3 Macleods Pharmaceuticals Amlodipine and Olmesartan Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.7.4 Macleods Pharmaceuticals Amlodipine and Olmesartan Products and Services

11.7.5 Macleods Pharmaceuticals Amlodipine and Olmesartan SWOT Analysis

11.7.6 Macleods Pharmaceuticals Recent Developments

11.8 Alembic Pharmaceuticals

11.8.1 Alembic Pharmaceuticals Corporation Information

11.8.2 Alembic Pharmaceuticals Overview

11.8.3 Alembic Pharmaceuticals Amlodipine and Olmesartan Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.8.4 Alembic Pharmaceuticals Amlodipine and Olmesartan Products and Services

11.8.5 Alembic Pharmaceuticals Amlodipine and Olmesartan SWOT Analysis

11.8.6 Alembic Pharmaceuticals Recent Developments

11.9 Ajanta Pharma

11.9.1 Ajanta Pharma Corporation Information

11.9.2 Ajanta Pharma Overview

11.9.3 Ajanta Pharma Amlodipine and Olmesartan Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.9.4 Ajanta Pharma Amlodipine and Olmesartan Products and Services

11.9.5 Ajanta Pharma Amlodipine and Olmesartan SWOT Analysis

11.9.6 Ajanta Pharma Recent Developments

11.10 Jubilant Pharma

11.10.1 Jubilant Pharma Corporation Information

11.10.2 Jubilant Pharma Overview

11.10.3 Jubilant Pharma Amlodipine and Olmesartan Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.10.4 Jubilant Pharma Amlodipine and Olmesartan Products and Services

11.10.5 Jubilant Pharma Amlodipine and Olmesartan SWOT Analysis

11.10.6 Jubilant Pharma Recent Developments

11.11 Accord Healthcare

11.11.1 Accord Healthcare Corporation Information

11.11.2 Accord Healthcare Overview

11.11.3 Accord Healthcare Amlodipine and Olmesartan Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.11.4 Accord Healthcare Amlodipine and Olmesartan Products and Services

11.11.5 Accord Healthcare Recent Developments

12 Value Chain and Sales Channels Analysis

12.1 Amlodipine and Olmesartan Value Chain Analysis

12.2 Amlodipine and Olmesartan Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Amlodipine and Olmesartan Production Mode & Process

12.4 Amlodipine and Olmesartan Sales and Marketing

12.4.1 Amlodipine and Olmesartan Sales Channels

12.4.2 Amlodipine and Olmesartan Distributors

12.5 Amlodipine and Olmesartan Customers

13 Research Findings and Conclusion

14 Appendix

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.2 Data Source

14.2 Author Details

14.3 Disclaimer

List of Tables

Table 1. Global Amlodipine and Olmesartan Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)

Table 2. Major Manufacturers of 5/20 mg Tablets

Table 3. Major Manufacturers of 10/20 mg Tablets

Table 4. Major Manufacturers of 5/40 mg Tablets

Table 5. Major Manufacturers of 10/40 mg Tablets

Table 6. Global Amlodipine and Olmesartan Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)

Table 7. Global Market Amlodipine and Olmesartan Market Size (US$ Million) by Region: 2016 VS 2021 VS 2027

Table 8. Global Amlodipine and Olmesartan Sales by Region (2016-2021) & (K Units)

Table 9. Global Amlodipine and Olmesartan Sales Market Share by Region (2016-2021)

Table 10. Global Amlodipine and Olmesartan Revenue by Region (2016-2021) & (US$ Million)

Table 11. Global Amlodipine and Olmesartan Revenue Market Share by Region (2016-2021)

Table 12. Global Amlodipine and Olmesartan Sales Forecast by Region (2022-2027) & (K Units)

Table 13. Global Amlodipine and Olmesartan Sales Market Share Forecast by Region (2022-2027)

Table 14. Global Amlodipine and Olmesartan Revenue Forecast by Region (2022-2027) & (US$ Million)

Table 15. Global Amlodipine and Olmesartan Revenue Market Share Forecast by Region (2022-2027)

Table 16. Top Amlodipine and Olmesartan Regions (Countries) Ranking by Market Size (US$ Million) in 2020

Table 17. Amlodipine and Olmesartan Market Trends

Table 18. Amlodipine and Olmesartan Market Drivers

Table 19. Amlodipine and Olmesartan Market Challenges

Table 20. Amlodipine and Olmesartan Market Restraints

Table 21. Global Amlodipine and Olmesartan Sales by Manufacturers (2016-2021) & (K Units)

Table 22. Global Amlodipine and Olmesartan Sales Share by Manufacturers (2016-2021)

Table 23. Global Amlodipine and Olmesartan Revenue by Manufacturers (2016-2021) & (US$ Million)

Table 24. Ranking of Global Top Amlodipine and Olmesartan Manufacturers by Revenue (US$ Million) in 2020

Table 25. Amlodipine and Olmesartan Revenue Share by Manufacturers (2016-2021)

Table 26. Global Amlodipine and Olmesartan Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 27. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Amlodipine and Olmesartan as of 2020)

Table 28. Key Manufacturers Amlodipine and Olmesartan Average Selling Price (ASP) & (2016-2021) & (USD/Unit)

Table 29. Key Manufacturers Amlodipine and Olmesartan Plants/Factories Distribution

Table 30. Key Manufacturers Amlodipine and Olmesartan Area Served

Table 31. Date of Key Manufacturers Enter into Amlodipine and Olmesartan Market

Table 32. Key Manufacturers Amlodipine and Olmesartan Product Type

Table 33. Mergers & Acquisitions, Expansion Plans

Table 34. Global Amlodipine and Olmesartan Sales (K Units) by Type (2016-2021)

Table 35. Global Amlodipine and Olmesartan Sales Share by Type (2016-2021)

Table 36. Global Amlodipine and Olmesartan Revenue (US$ Million) Market Share by Type (2016-2021)

Table 37. Global Amlodipine and Olmesartan Price (K Units) by Type (2016-2021)

Table 38. Global Amlodipine and Olmesartan Sales (K Units) by Type (2022-2027)

Table 39. Global Amlodipine and Olmesartan Sales Share by Type (2022-2027)

Table 40. Global Amlodipine and Olmesartan Revenue (US$ Million) Market Share by Type (2022-2027)

Table 41. Global Amlodipine and Olmesartan Revenue Share by Type (2022-2027)

Table 42. Global Amlodipine and Olmesartan Price (K Units) by Type (2022-2027)

Table 43. Global Amlodipine and Olmesartan Sales (K Units) by Application (2016-2021)

Table 44. Global Amlodipine and Olmesartan Sales Share by Application (2016-2021)

Table 45. Global Amlodipine and Olmesartan Revenue (US$ Million) Market Share by Application (2016-2021)

Table 46. Global Amlodipine and Olmesartan Price (K Units) by Application (2016-2021)

Table 47. Global Amlodipine and Olmesartan Sales (K Units) by Application (2022-2027)

Table 48. Global Amlodipine and Olmesartan Sales Share by Application (2022-2027)

Table 49. Global Amlodipine and Olmesartan Revenue (US$ Million) Market Share by Application (2022-2027)

Table 50. Global Amlodipine and Olmesartan Revenue Share by Application (2022-2027)

Table 51. Global Amlodipine and Olmesartan Price (K Units) by Application (2022-2027)

Table 52. North America Amlodipine and Olmesartan Sales by Company (2016-2021) & (K Units)

Table 53. North America Amlodipine and Olmesartan Sales Market Share by Company (2016-2021)

Table 54. North America Amlodipine and Olmesartan Revenue by Company (2016-2021) & (US$ Million)

Table 55. North America Amlodipine and Olmesartan Revenue Market Share by Company (2016-2021)

Table 56. North America Amlodipine and Olmesartan Sales by Application (2016-2021) & (K Units)

Table 57. North America Amlodipine and Olmesartan Sales by Application (2022-2027) & (K Units)

Table 58. North America Amlodipine and Olmesartan Revenue by Application (2016-2021) & (US$ Million)

Table 59. North America Amlodipine and Olmesartan Revenue by Application (2022-2027) & (US$ Million)

Table 60. North America Amlodipine and Olmesartan Sales by Application (2016-2021) & (K Units)

Table 61. North America Amlodipine and Olmesartan Sales by Application (2022-2027) & (K Units)

Table 62. North America Amlodipine and Olmesartan Revenue by Application (2016-2021) & (US$ Million)

Table 63. North America Amlodipine and Olmesartan Revenue by Application (2022-2027) & (US$ Million)

Table 64. North America Amlodipine and Olmesartan Sales by Country (2016-2021) & (K Units)

Table 65. North America Amlodipine and Olmesartan Sales by Country (2022-2027) & (K Units)

Table 66. North America Amlodipine and Olmesartan Revenue by Country (2016-2021) & (US$ Million)

Table 67. North America Amlodipine and Olmesartan Revenue by Country (2022-2027) & (US$ Million)

Table 68. Europe Amlodipine and Olmesartan Sales by Company (2016-2021) & (K Units)

Table 69. Europe Amlodipine and Olmesartan Sales Market Share by Company (2016-2021)

Table 70. Europe Amlodipine and Olmesartan Revenue by Company (2016-2021) & (US$ Million)

Table 71. Europe Amlodipine and Olmesartan Revenue Market Share by Company (2016-2021)

Table 72. Europe Amlodipine and Olmesartan Sales by Application (2016-2021) & (K Units)

Table 73. Europe Amlodipine and Olmesartan Sales by Application (2022-2027) & (K Units)

Table 74. Europe Amlodipine and Olmesartan Revenue by Application (2016-2021) & (US$ Million)

Table 75. Europe Amlodipine and Olmesartan Revenue by Application (2022-2027) & (US$ Million)

Table 76. Europe Amlodipine and Olmesartan Sales by Application (2016-2021) & (K Units)

Table 77. Europe Amlodipine and Olmesartan Sales by Application (2022-2027) & (K Units)

Table 78. Europe Amlodipine and Olmesartan Revenue by Application (2016-2021) & (US$ Million)

Table 79. Europe Amlodipine and Olmesartan Revenue by Application (2022-2027) & (US$ Million)

Table 80. Europe Amlodipine and Olmesartan Sales by Country (2016-2021) & (K Units)

Table 81. Europe Amlodipine and Olmesartan Sales by Country (2022-2027) & (K Units)

Table 82. Europe Amlodipine and Olmesartan Revenue by Country (2016-2021) & (US$ Million)

Table 83. Europe Amlodipine and Olmesartan Revenue by Country (2022-2027) & (US$ Million)

Table 84. Asia Pacific Amlodipine and Olmesartan Sales by Company (2016-2021) & (K Units)

Table 85. Asia Pacific Amlodipine and Olmesartan Sales Market Share by Company (2016-2021)

Table 86. Asia Pacific Amlodipine and Olmesartan Revenue by Company (2016-2021) & (US$ Million)

Table 87. Asia Pacific Amlodipine and Olmesartan Revenue Market Share by Company (2016-2021)

Table 88. Asia Pacific Amlodipine and Olmesartan Sales by Application (2016-2021) & (K Units)

Table 89. Asia Pacific Amlodipine and Olmesartan Sales by Application (2022-2027) & (K Units)

Table 90. Asia Pacific Amlodipine and Olmesartan Revenue by Application (2016-2021) & (US$ Million)

Table 91. Asia Pacific Amlodipine and Olmesartan Revenue by Application (2022-2027) & (US$ Million)

Table 92. Asia Pacific Amlodipine and Olmesartan Sales by Application (2016-2021) & (K Units)

Table 93. Asia Pacific Amlodipine and Olmesartan Sales by Application (2022-2027) & (K Units)

Table 94. Asia Pacific Amlodipine and Olmesartan Revenue by Application (2016-2021) & (US$ Million)

Table 95. Asia Pacific Amlodipine and Olmesartan Revenue by Application (2022-2027) & (US$ Million)

Table 96. Asia Pacific Amlodipine and Olmesartan Sales by Region (2016-2021) & (K Units)

Table 97. Asia Pacific Amlodipine and Olmesartan Sales by Region (2022-2027) & (K Units)

Table 98. Asia Pacific Amlodipine and Olmesartan Revenue by Region (2016-2021) & (US$ Million)

Table 99. Asia Pacific Amlodipine and Olmesartan Revenue by Region (2022-2027) & (US$ Million)

Table 100. Latin America Amlodipine and Olmesartan Sales by Company (2016-2021) & (K Units)

Table 101. Latin America Amlodipine and Olmesartan Sales Market Share by Company (2016-2021)

Table 102. Latin America Amlodipine and Olmesartan Revenue by Company (2016-2021) & (US$ Million)

Table 103. Latin America Amlodipine and Olmesartan Revenue Market Share by Company (2016-2021)

Table 104. Latin America Amlodipine and Olmesartan Sales by Application (2016-2021) & (K Units)

Table 105. Latin America Amlodipine and Olmesartan Sales by Application (2022-2027) & (K Units)

Table 106. Latin America Amlodipine and Olmesartan Revenue by Application (2016-2021) & (US$ Million)

Table 107. Latin America Amlodipine and Olmesartan Revenue by Application (2022-2027) & (US$ Million)

Table 108. Latin America Amlodipine and Olmesartan Sales by Application (2016-2021) & (K Units)

Table 109. Latin America Amlodipine and Olmesartan Sales by Application (2022-2027) & (K Units)

Table 110. Latin America Amlodipine and Olmesartan Revenue by Application (2016-2021) & (US$ Million)

Table 111. Latin America Amlodipine and Olmesartan Revenue by Application (2022-2027) & (US$ Million)

Table 112. Latin America Amlodipine and Olmesartan Sales by Country (2016-2021) & (K Units)

Table 113. Latin America Amlodipine and Olmesartan Sales by Country (2022-2027) & (K Units)

Table 114. Latin America Amlodipine and Olmesartan Revenue by Country (2016-2021) & (US$ Million)

Table 115. Latin America Amlodipine and Olmesartan Revenue by Country (2022-2027) & (US$ Million)

Table 116. Middle East and Africa Amlodipine and Olmesartan Sales by Company (2016-2021) & (K Units)

Table 117. Middle East and Africa Amlodipine and Olmesartan Sales Market Share by Company (2016-2021)

Table 118. Middle East and Africa Amlodipine and Olmesartan Revenue by Company (2016-2021) & (US$ Million)

Table 119. Middle East and Africa Amlodipine and Olmesartan Revenue Market Share by Company (2016-2021)

Table 120. Middle East and Africa Amlodipine and Olmesartan Sales by Application (2016-2021) & (K Units)

Table 121. Middle East and Africa Amlodipine and Olmesartan Sales by Application (2022-2027) & (K Units)

Table 122. Middle East and Africa Amlodipine and Olmesartan Revenue by Application (2016-2021) & (US$ Million)

Table 123. Middle East and Africa Amlodipine and Olmesartan Revenue by Application (2022-2027) & (US$ Million)

Table 124. Middle East and Africa Amlodipine and Olmesartan Sales by Application (2016-2021) & (K Units)

Table 125. Middle East and Africa Amlodipine and Olmesartan Sales by Application (2022-2027) & (K Units)

Table 126. Middle East and Africa Amlodipine and Olmesartan Revenue by Application (2016-2021) & (US$ Million)

Table 127. Middle East and Africa Amlodipine and Olmesartan Revenue by Application (2022-2027) & (US$ Million)

Table 128. Middle East and Africa Amlodipine and Olmesartan Sales by Country (2016-2021) & (K Units)

Table 129. Middle East and Africa Amlodipine and Olmesartan Sales by Country (2022-2027) & (K Units)

Table 130. Middle East and Africa Amlodipine and Olmesartan Revenue by Country (2016-2021) & (US$ Million)

Table 131. Middle East and Africa Amlodipine and Olmesartan Revenue by Country (2022-2027) & (US$ Million)

Table 132. Daiichi Sankyo Corporation Information

Table 133. Daiichi Sankyo Description and Overview

Table 134. Daiichi Sankyo Amlodipine and Olmesartan Sales (K Units), Revenue (Million US$), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2016-2021)

Table 135. Daiichi Sankyo Amlodipine and Olmesartan Product and Services

Table 136. Daiichi Sankyo Amlodipine and Olmesartan SWOT Analysis

Table 137. Daiichi Sankyo Recent Developments

Table 138. Teva Corporation Information

Table 139. Teva Description and Overview

Table 140. Teva Amlodipine and Olmesartan Sales (K Units), Revenue (Million US$), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2016-2021)

Table 141. Teva Amlodipine and Olmesartan Product and Services

Table 142. Teva Amlodipine and Olmesartan SWOT Analysis

Table 143. Teva Recent Developments

Table 144. Glenmark Pharmaceuticals Corporation Information

Table 145. Glenmark Pharmaceuticals Description and Overview

Table 146. Glenmark Pharmaceuticals Amlodipine and Olmesartan Sales (K Units), Revenue (Million US$), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2016-2021)

Table 147. Glenmark Pharmaceuticals Amlodipine and Olmesartan Product and Services

Table 148. Glenmark Pharmaceuticals Amlodipine and Olmesartan SWOT Analysis

Table 149. Glenmark Pharmaceuticals Recent Developments

Table 150. Matrix Laboratories Corporation Information

Table 151. Matrix Laboratories Description and Overview

Table 152. Matrix Laboratories Amlodipine and Olmesartan Sales (K Units), Revenue (Million US$), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2016-2021)

Table 153. Matrix Laboratories Amlodipine and Olmesartan Product and Services

Table 154. Matrix Laboratories Amlodipine and Olmesartan SWOT Analysis

Table 155. Matrix Laboratories Recent Developments

Table 156. Torrent Pharmaceuticals Corporation Information

Table 157. Torrent Pharmaceuticals Description and Overview

Table 158. Torrent Pharmaceuticals Amlodipine and Olmesartan Sales (K Units), Revenue (Million US$), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2016-2021)

Table 159. Torrent Pharmaceuticals Amlodipine and Olmesartan Product and Services

Table 160. Torrent Pharmaceuticals Amlodipine and Olmesartan SWOT Analysis

Table 161. Torrent Pharmaceuticals Recent Developments

Table 162. Aurobindo Corporation Information

Table 163. Aurobindo Description and Overview

Table 164. Aurobindo Amlodipine and Olmesartan Sales (K Units), Revenue (Million US$), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2016-2021)

Table 165. Aurobindo Amlodipine and Olmesartan Product and Services

Table 166. Aurobindo Amlodipine and Olmesartan SWOT Analysis

Table 167. Aurobindo Recent Developments

Table 168. Macleods Pharmaceuticals Corporation Information

Table 169. Macleods Pharmaceuticals Description and Overview

Table 170. Macleods Pharmaceuticals Amlodipine and Olmesartan Sales (K Units), Revenue (Million US$), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2016-2021)

Table 171. Macleods Pharmaceuticals Amlodipine and Olmesartan Product and Services

Table 172. Macleods Pharmaceuticals Amlodipine and Olmesartan SWOT Analysis

Table 173. Macleods Pharmaceuticals Recent Developments

Table 174. Alembic Pharmaceuticals Corporation Information

Table 175. Alembic Pharmaceuticals Description and Overview

Table 176. Alembic Pharmaceuticals Amlodipine and Olmesartan Sales (K Units), Revenue (Million US$), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2016-2021)

Table 177. Alembic Pharmaceuticals Amlodipine and Olmesartan Product and Services

Table 178. Alembic Pharmaceuticals Amlodipine and Olmesartan SWOT Analysis

Table 179. Alembic Pharmaceuticals Recent Developments

Table 180. Ajanta Pharma Corporation Information

Table 181. Ajanta Pharma Description and Overview

Table 182. Ajanta Pharma Amlodipine and Olmesartan Sales (K Units), Revenue (Million US$), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2016-2021)

Table 183. Ajanta Pharma Amlodipine and Olmesartan Product and Services

Table 184. Ajanta Pharma Amlodipine and Olmesartan SWOT Analysis

Table 185. Ajanta Pharma Recent Developments

Table 186. Jubilant Pharma Corporation Information

Table 187. Jubilant Pharma Description and Overview

Table 188. Jubilant Pharma Amlodipine and Olmesartan Sales (K Units), Revenue (Million US$), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2016-2021)

Table 189. Jubilant Pharma Amlodipine and Olmesartan Product and Services

Table 190. Jubilant Pharma Amlodipine and Olmesartan SWOT Analysis

Table 191. Jubilant Pharma Recent Developments

Table 192. Accord Healthcare Corporation Information

Table 193. Accord Healthcare Description and Overview

Table 194. Accord Healthcare Amlodipine and Olmesartan Sales (K Units), Revenue (Million US$), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2016-2021)

Table 195. Accord Healthcare Amlodipine and Olmesartan Product and Services

Table 196. Accord Healthcare Recent Developments

Table 197. Key Raw Materials Lists

Table 198. Raw Materials Key Suppliers Lists

Table 199. Amlodipine and Olmesartan Distributors List

Table 200. Amlodipine and Olmesartan Customers List

Table 201. Research Programs/Design for This Report

Table 202. Key Data Information from Secondary Sources

Table 203. Key Data Information from Primary Sources

List of Figures

Figure 1. Amlodipine and Olmesartan Product Picture

Figure 2. Global Amlodipine and Olmesartan Sales Market Share by Type in 2020 & 2027

Figure 3. 5/20 mg Tablets Picture

Figure 4. 10/20 mg Tablets Picture

Figure 5. 5/40 mg Tablets Picture

Figure 6. 10/40 mg Tablets Picture

Figure 7. Global Amlodipine and Olmesartan Sales Market Share by Application in 2020 & 2027

Figure 8. Hospital Use Case

Figure 9. Drug store Use Case

Figure 10. Amlodipine and Olmesartan Report Years Considered

Figure 11. Global Amlodipine and Olmesartan Revenue, (US$ Million), 2016 VS 2021 VS 2027

Figure 12. Global Amlodipine and Olmesartan Market Size 2016-2027 (US$ Million)

Figure 13. Global Amlodipine and Olmesartan Sales (2016-2021) & (K Units)

Figure 14. Global Amlodipine and Olmesartan Market Size Market Share by Region: 2020 VS 2027

Figure 15. Global Amlodipine and Olmesartan Sales Market Share by Region (2016-2021)

Figure 16. Global Amlodipine and Olmesartan Sales Market Share by Region in 2020

Figure 17. Global Amlodipine and Olmesartan Revenue Market Share by Region in 2016 VS 2020

Figure 18. Global Amlodipine and Olmesartan Sales Share by Manufacturers In 2020

Figure 19. The 5 and 10 Largest Manufacturers in the World: Market Share by Amlodipine and Olmesartan Sales in 2020

Figure 20. Amlodipine and Olmesartan Revenue Share by Manufacturers In 2020

Figure 21. Amlodipine and Olmesartan Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020

Figure 22. Global Amlodipine and Olmesartan Revenue Share by Type (2016-2021)

Figure 23. Global Amlodipine and Olmesartan Revenue Growth Rate by Type in 2016 & 2020

Figure 24. Global Amlodipine and Olmesartan Revenue Share by Application (2016-2021)

Figure 25. Global Amlodipine and Olmesartan Revenue Growth Rate by Application in 2016 & 2020

Figure 26. North America Amlodipine and Olmesartan Sales Market Share by Type (2016-2027)

Figure 27. North America Amlodipine and Olmesartan Revenue Market Share by Type (2016-2027)

Figure 28. North America Amlodipine and Olmesartan Sales Market Share by Application (2016-2027)

Figure 29. North America Amlodipine and Olmesartan Revenue Market Share by Application (2016-2027)

Figure 30. North America Amlodipine and Olmesartan Sales Share by Country (2016-2027)

Figure 31. North America Amlodipine and Olmesartan Revenue Share by Country (2016-2027)

Figure 32. U.S. Amlodipine and Olmesartan Revenue (2016-2027) & (US$ Million)

Figure 33. Canada Amlodipine and Olmesartan Revenue (2016-2027) & (US$ Million)

Figure 34. Europe Amlodipine and Olmesartan Sales Market Share by Type (2016-2027)

Figure 35. Europe Amlodipine and Olmesartan Revenue Market Share by Type (2016-2027)

Figure 36. Europe Amlodipine and Olmesartan Sales Market Share by Application (2016-2027)

Figure 37. Europe Amlodipine and Olmesartan Revenue Market Share by Application (2016-2027)

Figure 38. Europe Amlodipine and Olmesartan Sales Share by Country (2016-2027)

Figure 39. Europe Amlodipine and Olmesartan Revenue Share by Country (2016-2027)

Figure 40. Germany Amlodipine and Olmesartan Revenue (2016-2027) & (US$ Million)

Figure 41. France Amlodipine and Olmesartan Revenue (2016-2027) & (US$ Million)

Figure 42. U.K. Amlodipine and Olmesartan Revenue (2016-2027) & (US$ Million)

Figure 43. Italy Amlodipine and Olmesartan Revenue (2016-2027) & (US$ Million)

Figure 44. Russia Amlodipine and Olmesartan Revenue (2016-2027) & (US$ Million)

Figure 45. Asia Pacific Amlodipine and Olmesartan Sales Market Share by Type (2016-2027)

Figure 46. Asia Pacific Amlodipine and Olmesartan Revenue Market Share by Type (2016-2027)

Figure 47. Asia Pacific Amlodipine and Olmesartan Sales Market Share by Application (2016-2027)

Figure 48. Asia Pacific Amlodipine and Olmesartan Revenue Market Share by Application (2016-2027)

Figure 49. Asia Pacific Amlodipine and Olmesartan Sales Share by Region (2016-2027)

Figure 50. Asia Pacific Amlodipine and Olmesartan Revenue Share by Region (2016-2027)

Figure 51. China Amlodipine and Olmesartan Revenue (2016-2027) & (US$ Million)

Figure 52. Japan Amlodipine and Olmesartan Revenue (2016-2027) & (US$ Million)

Figure 53. South Korea Amlodipine and Olmesartan Revenue (2016-2027) & (US$ Million)

Figure 54. India Amlodipine and Olmesartan Revenue (2016-2027) & (US$ Million)

Figure 55. Australia Amlodipine and Olmesartan Revenue (2016-2027) & (US$ Million)

Figure 56. Taiwan Amlodipine and Olmesartan Revenue (2016-2027) & (US$ Million)

Figure 57. Indonesia Amlodipine and Olmesartan Revenue (2016-2027) & (US$ Million)

Figure 58. Thailand Amlodipine and Olmesartan Revenue (2016-2027) & (US$ Million)

Figure 59. Malaysia Amlodipine and Olmesartan Revenue (2016-2027) & (US$ Million)

Figure 60. Philippines Amlodipine and Olmesartan Revenue (2016-2027) & (US$ Million)

Figure 61. Vietnam Amlodipine and Olmesartan Revenue (2016-2027) & (US$ Million)

Figure 62. Latin America Amlodipine and Olmesartan Sales Market Share by Type (2016-2027)

Figure 63. Latin America Amlodipine and Olmesartan Revenue Market Share by Type (2016-2027)

Figure 64. Latin America Amlodipine and Olmesartan Sales Market Share by Application (2016-2027)

Figure 65. Latin America Amlodipine and Olmesartan Revenue Market Share by Application (2016-2027)

Figure 66. Latin America Amlodipine and Olmesartan Sales Share by Country (2016-2027)

Figure 67. Latin America Amlodipine and Olmesartan Revenue Share by Country (2016-2027)

Figure 68. Mexico Amlodipine and Olmesartan Revenue (2016-2027) & (US$ Million)

Figure 69. Brazil Amlodipine and Olmesartan Revenue (2016-2027) & (US$ Million)

Figure 70. Argentina Amlodipine and Olmesartan Revenue (2016-2027) & (US$ Million)

Figure 71. Middle East and Africa Amlodipine and Olmesartan Sales Market Share by Type (2016-2027)

Figure 72. Middle East and Africa Amlodipine and Olmesartan Revenue Market Share by Type (2016-2027)

Figure 73. Middle East and Africa Amlodipine and Olmesartan Sales Market Share by Application (2016-2027)

Figure 74. Middle East and Africa Amlodipine and Olmesartan Revenue Market Share by Application (2016-2027)

Figure 75. Middle East and Africa Amlodipine and Olmesartan Sales Share by Country (2016-2027)

Figure 76. Middle East and Africa Amlodipine and Olmesartan Revenue Share by Country (2016-2027)

Figure 77. Turkey Amlodipine and Olmesartan Revenue (2016-2027) & (US$ Million)

Figure 78. Saudi Arabia Amlodipine and Olmesartan Revenue (2016-2027) & (US$ Million)

Figure 79. U.A.E Amlodipine and Olmesartan Revenue (2016-2027) & (US$ Million)

Figure 80. Amlodipine and Olmesartan Value Chain

Figure 81. Amlodipine and Olmesartan Production Process

Figure 82. Channels of Distribution

Figure 83. Distributors Profiles

Figure 84. Bottom-up and Top-down Approaches for This Report

Figure 85. Data Triangulation

Figure 86. Key Executives Interviewed

Please fill the form below, to recieve the report sample


+1